Stocks · Health care · Pharmaceutical Preparations

iBio, Inc.

IBIO Clue Score37
United States Fiscal year ends June CIK 0001420720 Results filed 28 Aug 2026

What the insiders did Net selling

By person

14 insiders · 43 transactions
0.0×

Dr. Martin B. Brenner holds only 0.0 times base salary in stock. $53.95K of shares against $580.00K in salary for 2026.

Salary from the company's own proxy. The shares are what Dr. Martin B. Brenner last reported holding, valued at $1.76, the price Common Stock was last bought or sold at on the open market here, on 26 Mar 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Eastern Capital LTD entity
10% owner
$5.90M (3)
$98.17M (6)
−$92.27M
8,629,693
$15.19M
—
Antonio Bernardino Guimaraes Parada
Director
$500.00K (1)
—
+$500.00K
183,823
$323.53K
—
Robert L Erwin
President
—
$204.06K (2) scheduled
−$204.06K
108,108
$190.27K
0.0%
Felipe Duran
Chief Financial Officer
$75.13K (2)
—
+$75.13K
35,974
$63.31K
—
David Arkowitz
Director
$50.00K (1)
—
+$50.00K
18,382
$32.35K
—
Marc Banjak
Chief Legal Officer
$48.05K (3)
—
+$48.05K
25,000
$44.00K
+1,233%
Randy Joe Maddux
Chief Operating Officer
—
$25.44K (1)
−$25.44K
271,757
$478.29K
—
Gary Sender
Director
$25.00K (1)
—
+$25.00K
9,191
$16.18K
—
James P. Mullaney
Chief Financial Officer
—
$18.11K (1) scheduled
−$18.11K
0
$0.00
—
Martin Brenner
See Remarks
$49.92K (2)
$65.72K (15)
−$15.80K
30,652
$53.95K
—
Robert Matthew Lutz
See Remarks
—
$8.51K (1)
−$8.51K
102,165
$179.81K
—
William D Clark
Director
$5.00K (1)
—
+$5.00K
1,838
$3.23K
—
Kenneth Bryan Dart
10% owner
— (1)
—
$0.00
—
—
—
Thomas Francis 3rd Isett
CEO and Executive Chairman
—
—
—
1,275,000
$2.24M
+30.8%

No percentages here. This company's share count has moved by a factor of 6.5 over the window, from 9,874,676 to 64,307,256 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.